SEC EDGAR Filing Information

Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend]

Group Members: BRUCE F. WESSONDAVID JAHNSGALEN EMPLOYEE FUND III, L.P.GALEN PARTNERS III L PGALEN PARTNERS III, L.P.GALEN PARTNERS INTERNATIONAL III, L.P.L. JOHN WILKERSONSRINI CONJEEVARAMWILLIAM R. GRANTZUBEEN SCHROFF
Documents: 1

SEC Accession No.
0000950120-00-000009
Filing date: 2000-01-10
Accepted: 1995-09-28 00:00:00

Table of submitted documents:

Seq	Type	Document	Size	Description
1	SC 13D/A		23204	AMENDMENT NO. 3 TO SCHEDULE 13D

		0000950120-00-000009.txt	25534	Complete submission text file

Filer Information:

DERMA SCIENCES INC (Subject) (0000892160)
IRS No.: 232328753 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-52013 | Film No.: 504000
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
214 CARNEGIE CENTER, SUITE 100
PRINCETON NJ 08540
6095144744

Mailing Address
214 CARNEGIE CENTER, SUITE 100
PRINCETON NJ 08540

GALEN PARTNERS III L P (Filed by) (0001034486)
IRS No.: 133930452 | State of Incorp.: DE | Fiscal Year End: 1231

Business Address
610 FIFTH AVE
5TH FL
NEW YORK NY 10020
2122184990

Mailing Address
610 FIFTH AVE
5TH FL
NEW YORK NY 10020